These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27502825)

  • 1. Angiotensin-converting enzyme inhibitor-associated angioedema treated with c1-esterase inhibitor: A case report and review of the literature.
    Erickson DL; Coop CA
    Allergy Rhinol (Providence); 2016 Jan; 7(3):168-171. PubMed ID: 27502825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
    Culley CM; DiBridge JN; Wilson GL
    Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema.
    Greve J; Bas M; Hoffmann TK; Schuler PJ; Weller P; Kojda G; Strassen U
    Laryngoscope; 2015 Jun; 125(6):E198-202. PubMed ID: 25583256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.
    Riha HM; Summers BB; Rivera JV; Van Berkel MA
    J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
    Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
    Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema.
    Kovaltchouk U; Zhang B; Jain V; Kalicinsky C
    Allergy Asthma Clin Immunol; 2021 Feb; 17(1):18. PubMed ID: 33588931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ACEI-related angioedema with icatibant: a case series.
    Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
    Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
    Scalese MJ; Reinaker TS
    Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 Esterase Inhibitor (Berinert) for ACE Inhibitor-Induced Angioedema: Two Case Reports.
    Leibfried M; Kovary A
    J Pharm Pract; 2017 Dec; 30(6):668-671. PubMed ID: 27837046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency.
    Patel NS; Fung SM; Zanichelli A; Cicardi M; Cohn JR
    Allergy Asthma Proc; 2013; 34(1):72-7. PubMed ID: 23406939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin-mediated angioedema.
    Obtułowicz K
    Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Prolonged Angioedema After Cardiac Surgery.
    Mukhdomi T; Maslow A; Joyce MF
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1890-1896. PubMed ID: 31948888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema Related to Angiotensin-Converting Enzyme Inhibitors: Attack Severity, Treatment, and Hospital Admission in a Prospective Multicenter Study.
    Javaud N; Achamlal J; Reuter PG; Lapostolle F; Lekouara A; Youssef M; Hamza L; Karami A; Adnet F; Fain O
    Medicine (Baltimore); 2015 Nov; 94(45):e1939. PubMed ID: 26559262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novelties in the Diagnosis and Treatment of Angioedema.
    Cicardi M; Suffritti C; Perego F; Caccia S
    J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case series.
    Ibarra F; Cruz M
    J Am Pharm Assoc (2003); 2020; 60(6):e361-e364. PubMed ID: 32727672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
    Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
    Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of C1 Inhibitor for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Decreases Mechanical Ventilation Time.
    Urnoski E; Grillo A; Rosini JM
    J Emerg Med; 2015 Dec; 49(6):e173-5. PubMed ID: 26409672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.